Immune Pharmaceuticals Enters a Research Partnership to Develop...

2017-01-23T09:43:48-08:00

NEW YORK, Jan. 23, 2017 /PRNewswire/ — Immune Pharmaceuticals Inc. (NASDAQ: IMNP), “Immune”, a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of immuno-inflammatory diseases and cancers, announced today ...